AAV Vector-Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and...

Area of Science:

• Neuroscience
• Gene Therapy
• Molecular Biology

Background:

• Adeno-associated viral vectors (AAVs) are efficient tools for treating central nervous system (CNS) and peripheral nervous system (PNS) diseases.
• AAVs possess favorable characteristics like a robust safety profile, ability to cross the blood-brain barrier, and tropism for neuronal cells.
• Their high specificity makes them valuable for gene therapy in various neurological conditions.

Purpose of the Study:

• To investigate the role of AAV vectors carrying coding and non-coding RNAs in treating neurological disorders.
• To explore the relationship between AAV vectors and cellular signaling pathways.
• To examine the clinical applications of AAVs in diverse neurological diseases.

Main Methods:

• Review of existing literature on AAV vectors in neurological disease treatment.
• Analysis of studies utilizing AAVs in vitro, in vivo, and human clinical trials.
• Examination of AAV vector mechanisms involving coding and non-coding RNAs.

Main Results:

• AAVs are effective in managing and mitigating CNS and PNS disorders through cellular and molecular therapeutic strategies.
• AAVs facilitate the study of neurological diseases across various model systems.
• The review highlights the potential of AAVs for targeted gene delivery and therapeutic interventions.

Conclusions:

• AAV vectors are a promising and versatile tool for gene therapy in neurological disorders.
• Further research into AAVs carrying RNAs and their interaction with signaling pathways can advance treatment strategies.
• AAVs hold significant clinical potential for a wide range of neurological conditions.